1220071

Xellia Pharmaceuticals USA LLC — FEI 3012279857

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 29, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bedford, OH (United States)

Citations

IDCFRDescription
145221 CFR 211.113(b)Validation lacking for sterile drug products
440221 CFR 211.192Written record of investigation incomplete